EGFR and neoplasm: Recently, an anti-EGFR nanobody fused with the 5B9 tag at its C-terminal was shown to activate and redirect the UniCAR-T cell to the EGFR-positive tumor cells both in vitro and in a mouse tumor xenograft model.